sorafenib has been researched along with Stevens-Johnson Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, H; Kubota, Y; Kumada, N; Nagai, S; Teramoto, S | 1 |
| Amoh, Y; Fujita, T; Ikeda, M; Iwamura, M; Matsumoto, K; Mii, S | 1 |
2 other study(ies) available for sorafenib and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
[Metastatic Renal Cancer with Stevens-Johnson Syndrome after Nivolumab Treatment : A Case Report].
Topics: Aged; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Nivolumab; Sorafenib; Stevens-Johnson Syndrome | 2022 |
Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma.
Topics: Aged; Betamethasone; Carcinoma, Renal Cell; Fatal Outcome; Humans; Kidney Neoplasms; Male; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Prednisolone; Sirolimus; Skin; Sorafenib; Stevens-Johnson Syndrome | 2013 |